Broadcom: The Selloff Makes This Strong Buy Even Stronger

Broadcom (AVGO) posted strong Q2 2026 results, with revenue up 48% year over year and AI-driven performance underpinning the beat. Management’s guidance is described as realistic, with any near-term constraint tied to supply chain issues rather than demand or execution, while 2027–2028 EBITDA and free cash flow estimates were raised. Despite a post-earnings selloff, the multi-year outlook has improved and supports a stronger buy view.

Analysis

The key second-order takeaway is that AVGO’s “miss” in the market’s eyes is likely a supply-allocation story, not a demand story, which matters because constrained supply tends to preserve pricing power and keep backlog quality high. That shifts the debate from near-term optics to medium-term earnings power: if customer demand is intact but shipment timing is gated, the eventual revenue and margin catch-up can be mechanically stronger than the headline reaction implies.

The broader winner set extends beyond AVGO. Any hyperscaler or AI infra buyer with secure capacity contracts and the willingness to pre-fund supply should gain relative share versus slower-moving peers, because access to compute hardware and custom silicon becomes the real bottleneck. Conversely, less-capitalized competitors in networking, accelerators, and adjacent AI infrastructure risk seeing their design-win windows narrow as customers rationalize spend toward vendors that can actually deliver at scale.

The market may be underappreciating how guide-up in 2027–2028 estimates changes the valuation anchor. When long-dated free cash flow rises faster than near-term sentiment, the stock can de-rate on the print but re-rate on every subsequent revision cycle; that creates a setup where the next 2–3 quarters matter less than whether management continues to tighten multi-year visibility. The main tail risk is not a demand cliff, but either a genuine supply normalization that reveals weaker-than-expected mix, or an AI capex digestion period that causes customers to pause orders for a quarter or two.

Contrarian view: the post-earnings selloff may be overdone if investors are treating supply constraints as a negative rather than evidence of scarce, premium product. The consensus appears focused on the immediate guidance cadence, but the more important signal is that the company is still constrained while estimates are rising — a combination that historically supports multiple expansion once the market stops anchoring to the first print.

Key Decisions for Investors

• Buy AVGO on post-earnings weakness over the next 1-2 weeks; target 8-12% upside as the market refocuses on raised medium-term FCF rather than the initial guide reaction. Risk: if the next update shows demand normalization rather than supply timing, expect a fast retrace of 5-7%.
• Pair trade: long AVGO / short a basket of AI infrastructure laggards with weaker execution visibility over 1-3 months. The thesis is that constrained capacity and rising long-dated estimates favor the vendors with proven delivery, while slower peers lose share and pricing leverage.
• Sell downside protection only after implied volatility settles; consider a put spread overwrite on AVGO for 30-45 days if you already own the name. The risk/reward improves if the selloff was purely reflexive, but avoid naked short puts until the market digests whether supply constraints ease sooner than expected.
• For higher-conviction directional exposure, use AVGO call spreads 3-6 months out instead of stock if you want to express the rerating potential with defined risk. This works best if you expect estimate revisions to continue higher into the next two earnings cycles.
• Monitor hyperscaler capex commentary over the next quarter; if peers confirm AI spend remains strong, add to AVGO. If multiple customers signal budget digestion, trim 25-30% of the position because the stock will likely trade on that read-through before fundamentals fully roll over.